|
|
Scientific Symposium Invitation
|
|
|
|
|
|
Scientific Symposium
Tryptophan Hydroxylase:
A Potential New Target for
Carcinoid Syndrome
|
|
|
|
|
|
|
Date: Saturday, October 17
Time: 12:15 pm (lunch provided)
Location: Sheraton Austin Hotel at the Capitol, Ballroom D
|
|
|
|
|
|
SPEAKER PROGRAM
|
|
|
|
Pablo Lapuerta, MD
|
Executive Vice President and
Chief Medical Officer
Lexicon Pharmaceuticals
|
| |
Opening Remarks
|
|
|
|
Marianne Pavel, MD
|
Department of Gastroenterology,
Hepatology, and Endocrinology
Charité University Hospital,
Berlin, Germany
|
| |
Symposium Overview and Objectives
|
|
|
|
Lowell Anthony, MD
|
Professor of Medicine and Chief,
Division of Medical Oncology
University of Kentucky
|
| |
Continuous Challenges in Serotonin Overproduction
|
|
|
|
Matthew Kulke, MD
|
Director, Program in Neuroendocrine
and Carcinoid Tumors
Senior Physician, Dana-Farber
Cancer Institute
Associate Professor of Medicine,
Harvard Medical School
|
| |
TELESTAR Program and Phase III Data Review
|
|
|
|
Pamela Kunz, MD
|
Assistant Professor of
Medicine-Oncology
Stanford University Medical Center
|
| |
The Patient Perspective:
Patient-reported Outcomes
|
|
|
|
Expert Panel Discussion
Moderator: Marianne Pavel, MD
|
|
|
|
|
|
To RSVP or for registration details,
please contact
SymposiumReg@LexPharmaSymposia.com
or register at the
Lexicon Pharmaceuticals booth, at the
Sheraton Hotel Grand Ballroom Foyer
|
|
|
|
|
|
|
|
|
|
|
Copyright © 2015, Lexicon Pharmaceuticals, Inc.
All rights reserved. LXRX0007.
Lexicon Pharmaceuticals, Inc.
8800 Technology Forest Place
The Woodlands, TX 77381-1160
|
|
|
|